Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle
- PMID: 2970619
- DOI: 10.1203/00006450-198807000-00021
Receptor-mediated uptake of acid alpha-glucosidase corrects lysosomal glycogen storage in cultured skeletal muscle
Abstract
Attempts at treatment of glycogenosis type II and other lysosomal storage disorders by enzyme replacement have been reported. Parenteral enzyme administration has been ineffectual. Treatment by bone marrow transplantation is currently under investigation. We have used cultured skeletal muscle cells from a patient with infantile glycogenosis type II to study fundamental aspects of enzyme replacement therapy. Efficient uptake of acid alpha-glucosidase was achieved by using the mannose-6-phosphate receptor on the cell surface as a target for an enzyme precursor with phosphorylated high-mannose types carbohydrate chains purified from human urine. We found that the enzyme was channeled to the lysosomes and converted to mature acid alpha-glucosidase. Glycogen storage was reversed. The results are discussed in relation to treatment of glycogenosis type II.
Similar articles
-
Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts.Pediatr Res. 1998 Mar;43(3):374-80. doi: 10.1203/00006450-199803000-00011. Pediatr Res. 1998. PMID: 9505277
-
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.Mol Ther. 2005 Jan;11(1):48-56. doi: 10.1016/j.ymthe.2004.09.017. Mol Ther. 2005. PMID: 15585405
-
Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients.Exp Cell Res. 1984 Nov;155(1):178-89. doi: 10.1016/0014-4827(84)90779-1. Exp Cell Res. 1984. PMID: 6237928
-
[Lysosomal glycogen storage disease without acid maltase deficiency(Danon disease)].Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):491-2. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11032005 Review. Japanese. No abstract available.
-
[Chemical galactosylation of acid alpha-glucosidase to provide directed transport of the enzyme into lysosomes of liver parenchymal cells].Vopr Med Khim. 1987 Sep-Oct;33(5):15-20. Vopr Med Khim. 1987. PMID: 2825427 Review. Russian.
Cited by
-
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase.J Biol Chem. 2021 Jan-Jun;296:100769. doi: 10.1016/j.jbc.2021.100769. Epub 2021 May 8. J Biol Chem. 2021. PMID: 33971197 Free PMC article.
-
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patients.J Inherit Metab Dis. 2020 Nov;43(6):1243-1253. doi: 10.1002/jimd.12268. Epub 2020 Jul 13. J Inherit Metab Dis. 2020. PMID: 32506446 Free PMC article.
-
Challenges in treating Pompe disease: an industry perspective.Ann Transl Med. 2019 Jul;7(13):291. doi: 10.21037/atm.2019.04.15. Ann Transl Med. 2019. PMID: 31392203 Free PMC article. Review.
-
The impact of Pompe disease on smooth muscle: a review.J Smooth Muscle Res. 2018;54(0):100-118. doi: 10.1540/jsmr.54.100. J Smooth Muscle Res. 2018. PMID: 30787211 Free PMC article. Review.
-
Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study.J Inherit Metab Dis. 2016 May;39(3):383-390. doi: 10.1007/s10545-015-9912-y. Epub 2016 Jan 14. J Inherit Metab Dis. 2016. PMID: 26768149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources